Wendy's initiated with a Neutral at Seaport Research

Domino's Pizza initiated with a Neutral at Seaport Research

Chipotle initiated with a Neutral at Seaport Research

Shake Shack initiated with a Neutral at Seaport Research

Starbucks initiated with a Neutral at Seaport Research

McDonald's initiated with a Neutral at Seaport Research

Texas Roadhouse initiated with a Buy at Seaport Research

Darden initiated with a Buy at Seaport Research

Brinker initiated with a Buy at Seaport Research

Yum! Brands initiated with a Buy at Seaport Research

Restaurant Brands initiated with a Buy at Seaport Research

Cava Group initiated with a Buy at Seaport Research

Dutch Bros initiated with a Buy at Seaport Research

KBC Group initiated with a Buy at Jefferies

Athabasca Oil downgraded to Market Perform from Outperform at BMO Capital

Acushnet Holdings initiated with an Equal Weight at Stephens

Faeth Therapeutics initiated with a Buy at Guggenheim

Braskem downgraded to Sell from Neutral at UBS

Zentalis initiated with an Outperform at William Blair

Rexford Industrial upgraded to Market Perform from Underperform at Raymond James

Ramsay Health Care upgraded to Outperform from Sector Perform at RBC Capital

Fisher & Paykel Healthcare upgraded to Outperform at RBC Capital

CSL upgraded to Outperform from Sector Perform at RBC Capital

Nanosonics upgraded to Outperform from Sector Perform at RBC Capital

Intel price target raised to $145 from $118 at Tigress Financial

FTAI Aviation price target lowered to $310 from $350 at Barclays

Uber price target lowered to $101 from $103 at BofA

SSAB AB price target raised to SEK 120 from SEK 110 at Citi

Outokumpu price target raised to EUR 6 from EUR 5.70 at Citi

Acerinox price target raised to EUR 20 from EUR 18 at Citi

Unicaja Banco price target raised to EUR 3.33 from EUR 3.25 at Citi

Banco Sabadell price target raised to EUR 3.57 from EUR 3.25 at Citi

MasterCraft Boat price target lowered to $22 from $25 at B. Riley

Orion Energy price target raised to $43 from $40 at Craig-Hallum

DHL Group price target raised to EUR 62 from EUR 60 at Deutsche Bank

Citi: 'We See a Wide Variety of Buyers for WAY'

Evertz Technologies price target lowered to C$16 from C$17 at RBC Capital

Cineplex price target raised to C$15 from C$14 at RBC Capital

Evertz Technologies price target lowered to C$17 from C$18 at BMO Capital

BCE price target raised to C$40 from C$37 at TD Securities

AGF Management price target lowered to C$23 from C$24 at TD Securities

Piper Sandler: 'We remain bullish on AMD (AMD)'

Piper Sandler on Guardant Health (GH): 'Investors can take this opportunity to add to their position'

Piper Sandler on Kestra Medical Technologies (KMTS): 'Buy The Dip on Leverage Concerns'

KeyBanc Reiterates Overweight Rating on Broadstone Net Lease (BNL)

BMO on Obsidian Energy Ltd. (OBE:CN) (OBE): 'We expect investors to remain focused on Peace River execution'

TD Cowen Reiterates Buy Rating on Vera Therapeutics (VERA)

Odds seen as stacked against Clarity Act as Senate readies vote

Genworth price target lowered to $11.50 from $12 at Keefe Bruyette

Vera Therapeutics ORIGIN 3 study results positive, says Raymond James

Ulta Beauty, Etsy upgraded: Wall Street's top analyst calls

Ulta Beauty, Etsy upgraded: Wall Street's top analyst calls

Ulta Beauty, Etsy upgraded: Wall Street's top analyst calls

Ulta Beauty, Etsy upgraded: Wall Street's top analyst calls

Ulta Beauty, Etsy upgraded: Wall Street's top analyst calls

Ulta Beauty, Etsy upgraded: Wall Street's top analyst calls

Ulta Beauty, Etsy upgraded: Wall Street's top analyst calls

Ulta Beauty, Etsy upgraded: Wall Street's top analyst calls

Cantor Fitzgerald Reiterates Overweight Rating on MiMedx Group (MDXG)

RBC views Waystar as attractive target after Reuters report

Cantor Fitzgerald Reiterates Overweight Rating on Nyxoah SA (NYXH)

Cantor Fitzgerald Reiterates Overweight Rating on NeuroPace Inc (NPCE)

Cantor Fitzgerald: Robinhood Markets (HOOD) Best Positioned to Benefit From Institutional Adoption of Prediction Markets

UBS Reiterates Buy Rating on Scholar Rock (SRRK)

UBS Reiterates Buy Rating on Dynatrace Inc. (DT) on Solid Growth Outlook

UBS Reiterates Neutral Rating on Hub Group (HUBG)

FuelCell initiated with a Neutral at Citi

GEK Terna initiated with a Buy at Jefferies

UBS Reiterates Buy Rating on AutoZone (AZO), Says Earnings to Be an Inflection Point for Stock

UBS Reiterates Buy Rating on Comfort Systems USA (FIX) on Continued Market Traction

Enbridge price target raised to C$80 from C$79 at Raymond James

RF Industries price target lowered to $17 from $19 at Lake Street

Flotek price target raised to $44 from $40 at Lake Street

Paysign price target raised to $15 from $13 at Lake Street

Carnival price target lowered to $29 from $34 at Deutsche Bank

ACV Auctions downgraded to Market Perform from Outperform at CJS Securities

Orchestra BioMed price target raised to $11 from $10 at B. Riley

Luckin Coffee upgraded to Outperform from Neutral at BNP Paribas

BofA reaction to weaker capital markets activity 'overdone,' says Morgan Stanley

Scholar Rock price target raised to $72 from $65 at Evercore ISI

Benitec Biopharma price target raised to $17 from $16 at Wedbush

Sionna Therapeutics price target raised to $6 from $5 at Wedbush

Thor Industries price target lowered to $95 from $110 at BMO Capital

Scholar Rock price target raised to $70 from $64 at Wedbush

Dave & Buster's price target lowered to $13 from $22 at BMO Capital

Darden price target raised to $245 from $235 at Oppenheimer

Dynatrace price target raised to $62 from $60 at BMO Capital

Baldwin Group price target raised to $32.50 from $26 at BMO Capital

Alterity Therapeutics initiated with a Buy at Lake Street

Palantir price target raised to $250 from $220 at UBS

Comcast price target lowered to $26 from $32 at UBS

Vivmark Residential price target raised to $75 from $73 at UBS

Zebra Technologies price target raised to $435 from $410 at Needham

The Elmet Group (ELMT) PT Raised to $25 at Needham

Eos Energy Enterprises (EOSE) PT Lowered to $10 at Needham

Symbotic Inc. (SYM) PT Lowered to $60 at Needham

H.C. Wainwright Reiterates Buy Rating on Corbus Pharmaceuticals (CRBP)

H.C. Wainwright Reiterates Buy Rating on Definium Therapeutics Inc (DFTX)

H.C. Wainwright Reiterates Buy Rating on Definium Therapeutics Inc (DFTX)

West Fraser Timber upgraded to Outperform from Market Perform at Raymond James